Manuel Solís-Moruno

428 total citations
7 papers, 49 citations indexed

About

Manuel Solís-Moruno is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Manuel Solís-Moruno has authored 7 papers receiving a total of 49 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Immunology. Recurrent topics in Manuel Solís-Moruno's work include Immunodeficiency and Autoimmune Disorders (3 papers), Genomics and Rare Diseases (2 papers) and Cancer Genomics and Diagnostics (2 papers). Manuel Solís-Moruno is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (3 papers), Genomics and Rare Diseases (2 papers) and Cancer Genomics and Diagnostics (2 papers). Manuel Solís-Moruno collaborates with scholars based in Spain and United Kingdom. Manuel Solís-Moruno's co-authors include Ferrán Casals, Tomàs Marquès‐Bonet, Juan I. Aróstegui, Anna Mensa‐Vilaró, Núria Bonet, Ashraf Muhaisen, Jesús Ávila, Raheleh Rahbari, Irene Lobón and Federico Abascal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Manuel Solís-Moruno

7 papers receiving 49 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Solís-Moruno Spain 6 29 15 13 11 4 7 49
Anna Krasnenko Russia 6 31 1.1× 10 0.7× 13 1.0× 6 0.5× 5 1.3× 11 63
Alexandr Boytsov Russia 3 88 3.0× 28 1.9× 13 1.0× 14 1.3× 5 1.3× 5 113
Majid Changi‐Ashtiani Iran 4 26 0.9× 12 0.8× 10 0.8× 4 0.4× 3 0.8× 10 46
Ikeoluwa Osei‐Owusu United States 2 28 1.0× 32 2.1× 5 0.4× 15 1.4× 3 0.8× 4 57
Sergey Abramov Russia 4 88 3.0× 28 1.9× 17 1.3× 14 1.3× 6 1.5× 7 118
Abdullah Alfaifi Saudi Arabia 3 41 1.4× 23 1.5× 6 0.5× 6 0.5× 3 0.8× 4 66
Olin Blodgett United States 2 54 1.9× 16 1.1× 8 0.6× 5 0.5× 3 0.8× 2 78
Eisa Mahyari United States 4 39 1.3× 25 1.7× 6 0.5× 8 0.7× 5 1.3× 7 64
Slobodan Lazarevski North Macedonia 3 24 0.8× 22 1.5× 7 0.5× 21 1.9× 4 1.0× 5 51
Matthew R. Schaner United States 4 18 0.6× 14 0.9× 14 1.1× 6 0.5× 7 45

Countries citing papers authored by Manuel Solís-Moruno

Since Specialization
Citations

This map shows the geographic impact of Manuel Solís-Moruno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Solís-Moruno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Solís-Moruno more than expected).

Fields of papers citing papers by Manuel Solís-Moruno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Solís-Moruno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Solís-Moruno. The network helps show where Manuel Solís-Moruno may publish in the future.

Co-authorship network of co-authors of Manuel Solís-Moruno

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Solís-Moruno. A scholar is included among the top collaborators of Manuel Solís-Moruno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Solís-Moruno. Manuel Solís-Moruno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bonet, Núria, Manuel Solís-Moruno, Anna Mensa‐Vilaró, et al.. (2024). Case report: Novel compound heterozygous IL1RN mutations as the likely cause of a lethal form of deficiency of interleukin-1 receptor antagonist. Frontiers in Immunology. 15. 1381447–1381447. 1 indexed citations
2.
Solís-Moruno, Manuel, et al.. (2022). Somatic genetic variation in healthy tissue and non-cancer diseases. European Journal of Human Genetics. 31(1). 48–54. 7 indexed citations
3.
Lobón, Irene, Manuel Solís-Moruno, David Juan, et al.. (2022). Somatic Mutations Detected in Parkinson Disease Could Affect Genes With a Role in Synaptic and Neuronal Processes. SHILAP Revista de lepidopterología. 3. 851039–851039. 9 indexed citations
4.
Solís-Moruno, Manuel, Anna Mensa‐Vilaró, Irene Lobón, et al.. (2021). Assessment of the gene mosaicism burden in blood and its implications for immune disorders. Scientific Reports. 11(1). 12940–12940. 6 indexed citations
5.
Kuderna, Lukas F. K., Manuel Solís-Moruno, Eva Julià, et al.. (2020). Flow Sorting Enrichment and Nanopore Sequencing of Chromosome 1 From a Chinese Individual. Frontiers in Genetics. 10. 1315–1315. 5 indexed citations
6.
Mensa‐Vilaró, Anna, et al.. (2020). Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing. European Journal of Medical Genetics. 63(5). 103920–103920. 16 indexed citations
7.
Solís-Moruno, Manuel, Marc de Manuel, Jessica Hernández-Rodríguez, et al.. (2017). Potential damaging mutation in LRP5 from genome sequencing of the first reported chimpanzee with the Chiari malformation. Scientific Reports. 7(1). 15224–15224. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026